跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Thromboreductin - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Thromboreductin
Approved
STANDARD
Thromboreductin
Haupt Pharma Wolfratshausen GmbH
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ddcc51a10ae1977f
Company
Haupt Pharma Wolfratshausen GmbH
Type
Standard
Approval Details
Approval Id
ddcc51a10ae1977f
Drug Approval Philippines Name
Thromboreductin
Product Name
Thromboreductin
Registration Number
DR-XY32281
Brand Name
Thromboreductin
Generic Name
Anagrelide (As Hydrochloride)
Dosage Form
Capsule
Dosage Strength
500mcg
Manufacturer
Haupt Pharma Wolfratshausen GmbH
Importer
Globo Asiatico Enterprises Inc.
Distributor
Globo Asiatico Enterprises Inc.
Company Detail Path
/organization/haupt-pharma-wolfratshausen-gmbh
Issuance Date
18 July 2023
Expiry Date
20 September 2028
Pharmacologic Category
Antineoplastic Agent
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ddcc51a10ae1977f
Type
Standard
Back to Philippines FDA Approvals